development of ARVC
ARVC patients
potential targets
therapeutic targets
novel RNA-based targets
innovative potential
hereditary disease
EF programme
host organisations
fibro-fatty tissue
disadvantageous environmental stimuli
academic organisations active
relevance of disease mechanisms
main research objective
mouse models
linked components
terms of skill acquisition
common sequence variants
myocardium
miRNAs
individual competence
endogenous factors
progressive substitution
epigenetic modifiers
modifier genes
field of molecular cardiology
complementary training
onset of complex
heterogeneous diseases
successful European scientist
right ventricle
wide variation
individuals
MicroRNAs
secondments